Head and neck cancer care at a community-based teaching hospital.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 15825202.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The purpose of this analysis was to demonstrate that the National Cancer Institute (NCI) Community Clinical Oncology Program (CCOP) will result in accruals to national research protocols for patients with malignancies in a community-based teaching hospital. We retrospectively reviewed the records of oncology patients eligible for clinical trials referred to the Helen F. Graham Cancer Center (HFGCC). The average number of patients who actually enroll in clinical trials nationally is 2.5%. The number of patients who enrolled in clinical trials at the HFGCC CCOP in 2003 was 24%. The integration of a CCOP in a community-based teaching hospital will enhance adoption of state-of-the-art care and increase accruals to national research protocols.
Medical subject headings
- Clinical Trials as Topic
- Head and Neck Neoplasms
- Hospitals, Community
- Hospitals, Teaching
- Program Evaluation